Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Delayed
OTC Markets
22:27:10 10/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.84M 1.73M 1.57M 2.96M 204M 3M 20.29M 7.95M 102M 7.99M 7.82M 340M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.82M 5.48M 4.98M 9.37M 646M 9.5M 64.28M 25.19M 323M 25.32M 24.77M 1.08B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% | 2.13K | ||
| -1.01% | +8.24% | -11.57% | +30.69% | 3.41B | ||
| +0.95% | +7.51% | +39.11% | +1,360.06% | 2.99B | ||
| +3.03% | -0.19% | +28.54% | +431.82% | 2.4B | ||
| +2.58% | -0.10% | -31.54% | -16.23% | 1.76B | ||
| +12.71% | 0.00% | +158.23% | +558.06% | 1.38B | ||
| -1.89% | -6.56% | +9.49% | +22.18% | 613M | ||
| +2.86% | +3.77% | +16.43% | +29.71% | 321M | ||
| +3.37% | -5.48% | +46.03% | +72.50% | 188M | ||
| -0.72% | -1.43% | +38.00% | +84.00% | 120M | ||
| Average | +2.19% | -0.61% | +29.27% | +257.28% | 1.32B | |
| Weighted average by Cap. | +2.20% | +0.76% | +25.26% | +455.28% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.24M 13.4M 12.17M 22.9M 1.58B 23.23M 157M 61.58M 790M 61.89M 60.55M 2.63B | 14.01M 12.1M 11.39M 10.35M 19.46M 1.34B 19.75M 134M 52.34M 671M 52.61M 51.47M 2.24B |
| Net income | -4.29M -3.71M -3.49M -3.17M -5.96M -411M -6.05M -40.91M -16.03M -206M -16.11M -15.76M -685M | -7.61M -6.57M -6.18M -5.62M -10.57M -729M -10.72M -72.52M -28.42M -365M -28.56M -27.94M -1.21B |
| Net Debt | 3.04M 2.63M 2.47M 2.25M 4.23M 292M 4.29M 29.01M 11.37M 146M 11.42M 11.18M 486M | 4.62M 3.99M 3.75M 3.41M 6.41M 442M 6.5M 43.99M 17.24M 221M 17.33M 16.95M 737M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















